Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration

[1]  L. V. Johnson,et al.  Complement activation and inflammatory processes in Drusen formation and age related macular degeneration. , 2001, Experimental eye research.

[2]  P T de Jong,et al.  An international classification and grading system for age-related maculopathy and age-related macular degeneration , 1995 .

[3]  C. Osmond,et al.  Association of HLA class I and class II polymorphisms with age-related macular degeneration. , 2005, Investigative ophthalmology & visual science.

[4]  A. Hofman,et al.  REVIEW: Epidemiology of age-related maculopathy: a review , 2003, European Journal of Epidemiology.

[5]  B S Hawkins,et al.  Epidemiology of age-related macular degeneration. , 1999, Molecular vision.

[6]  Ted Suie,et al.  Department of Ophthalmology , 1969 .

[7]  J. Lupski,et al.  Mutation of the Stargardt disease gene (ABCR) in age-related macular degeneration. , 1997, Science.

[8]  R. Allikmets,et al.  Evaluation of the ARMD1 locus on 1q25–31 in patients with age-related maculopathy: genetic variation in laminin genes and in exon 104 of HEMICENTIN-1 , 2004, Ophthalmic genetics.

[9]  R. T. Smith,et al.  A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[10]  J. Ott,et al.  Complement Factor H Polymorphism in Age-Related Macular Degeneration , 2005, Science.

[11]  A. Edwards,et al.  Complement Factor H Polymorphism and Age-Related Macular Degeneration , 2005, Science.

[12]  Masaru Miyagi,et al.  Drusen proteome analysis: An approach to the etiology of age-related macular degeneration , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[13]  T. Kinoshita.  Biology of complement: the overture. , 1991, Immunology today.

[14]  C. Larsen,et al.  The genetics of HLA-associated disease. , 2004, Current opinion in immunology.

[15]  J. Thurman,et al.  The alternative pathway of complement in disease: opportunities for therapeutic targeting. , 2004, Molecular immunology.

[16]  Robert F Mullins,et al.  A role for local inflammation in the formation of drusen in the aging eye. , 2002, American journal of ophthalmology.

[17]  Jurg Ott,et al.  Strong association of the Y402H variant in complement factor H at 1q32 with susceptibility to age-related macular degeneration. , 2005, American journal of human genetics.

[18]  Robert F. Mullins,et al.  An Integrated Hypothesis That Considers Drusen as Biomarkers of Immune-Mediated Processes at the RPE-Bruch's Membrane Interface in Aging and Age-Related Macular Degeneration , 2001, Progress in Retinal and Eye Research.

[19]  P. Densen,et al.  Immunoglobulin Deficiencies and Susceptibility to Infection Among Homozygotes and Heterozygotes for C2 Deficiency , 2003, Journal of Clinical Immunology.

[20]  D. Weeks,et al.  Candidate gene analysis suggests a role for fatty acid biosynthesis and regulation of the complement system in the etiology of age-related maculopathy. , 2005, Human molecular genetics.

[21]  J. Gilbert,et al.  Complement Factor H Variant Increases the Risk of Age-Related Macular Degeneration , 2005, Science.

[22]  D. J. Unsworth,et al.  Complement deficiency and disease , 2008, Journal of Clinical Pathology.

[23]  M. Lokki,et al.  Allelic differences in hemolytic activity and protein concentration of BF molecules are found in association with particular HLA haplotypes , 2004, Immunogenetics.

[24]  Sophie Palmer,et al.  Complete MHC haplotype sequencing for common disease gene mapping. , 2004, Genome research.

[25]  P. Schur,et al.  Mapping of the structural gene for the second component of complement with respect to the human major histocompatibility complex. , 1979, American journal of human genetics.

[26]  S. Russell,et al.  Drusen associated with aging and age‐related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[27]  C. A. Davis,et al.  Partial properdin deficiency. , 1980, The Journal of laboratory and clinical medicine.

[28]  P. Donnelly,et al.  A Fine-Scale Map of Recombination Rates and Hotspots Across the Human Genome , 2005, Science.

[29]  A Hofman,et al.  Incidence and progression rates of age-related maculopathy: the Rotterdam Study. , 2001, Investigative ophthalmology & visual science.

[30]  D. Bok.  Evidence for an inflammatory process in age-related macular degeneration gains new support. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[31]  L. Senelick.  It (review) , 2008 .

[32]  Albert Hofman,et al.  Epidemiology of age-related maculopathy: a review. , 2003, European journal of epidemiology.

[33]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .